Patients with SS-HCV had a lower frequency of isolated anti-Ro antibodies and a higher frequency of isolated anti-La antibodies compared with SS patients without HCV infection (36 % vs. 19 % and 24 % vs. 7 %, respectively, P=0.014). The gene discussed is CALR; the disease is synovial sarcoma.